Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer.

Journal: Journal of gynecologic oncology
Published Date: Sep 1, 2018

Abstract

OBJECTIVE: Accumulating evidence support that complete cytoreduction (CC) at the time of secondary cytoreductive surgery (SCS) improves survival in patients affected by recurrent ovarian cancer (ROC). Here, we aimed to determine whether artificial intelligence (AI) might be useful in weighting the importance of clinical variables predicting CC and survival.

Authors

  • Giorgio Bogani
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy. giorgiobogani@yahoo.it.
  • Diego Rossetti
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
  • Antonino Ditto
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
  • Fabio Martinelli
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
  • Valentina Chiappa
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
  • Lavinia Mosca
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
  • Umberto Leone Roberti Maggiore
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
  • Stefano Ferla
    Division of Gynaecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. Electronic address: stefano.ferla2@studio.unibo.it.
  • Domenica Lorusso
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
  • Francesco Raspagliesi
    Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.

Keywords

External Resources

Popular Topics
Recent Journals